Proteome shares rise on EU funding; Prostate marker could help surgery decisions;

> A team of researchers in Ireland have validated a prostate biomarker that could support accurate preoperative staging of prostate cancer, helping doctors make better treatment decisions. Abstract

> Astute Medical expects to launch its NephroCheck Test, a biomarker-based test for acute kidney injury in critically ill patients, in Europe this year. Press release

> Biomarker company Proteome Sciences' ($PRM.L) shares have risen on the news that Euro-HYP-1, the consortium of academic, clinical and industrial European partners that includes Proteome, has received an €11 million ($14.6 million) award for research into stroke. Article

> In non-small cell lung cancer patients treated with the targeted drug erlotinib, finding new lesions using 18F-FDG PET is a potential surrogate biomarker for survival. Abstract

> Researchers have shown the first signs that the Wnt signaling pathway may include a biomarker for scleroderma but also said that more research is needed. Press release

> A blood test based on ischemia-modified albumin is a potential diagnostic biomarker in diabetic ketosis. Abstract

> Serum biomarkers were predictive of higher frequencies of seizures in people with temporal lobe epilepsy. Abstract

> DNA methylation (the addition of small groups on DNA strands) may be a biomarker for schizophrenia. Abstract

> Restore Biodiagnostics has received a National Institutes of Health grant to develop a rapid point of care saliva test to assess stress levels, based on the stress biomarker cortisol. Press release

> NextGen Sciences Dx has filed for intellectual property on a combination of protein biomarkers with the potential for diagnosing changes in cognition for patients with early-stage dementia. Press release

> Protagen and the University of Tübingen are collaborating to develop multiplex assays for diagnosing autoimmune diseases and cancer. Article

> Taiwanese university National Cheng Kung University has signed a memorandum of understanding with Ohio State University College of Pharmacy to develop diagnostic markers and therapeutic agents for pancreatic cancer. Press release

> Finding the peptide megalin in the urine could mark the development and severity of diabetic nephropathy. Article

> HealthLinx is carrying out a study to support the South Korean submission of its biomarker-based ovarian cancer diagnostic test, OvPlex. Article

And Finally… David Alland of UMDNJ has received a tuberculosis biomarkers grant from the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program. Article

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.